Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating children with congestive splenomegaly

A congestive, splenomegaly technology, applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of liver cell damage, no benefit of surgical treatment, mild adverse reactions, etc., to relieve portal hypertension, unique formula , delaying the effect of splenomegaly

Inactive Publication Date: 2013-03-27
武英
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above-mentioned surgical treatment has the following disadvantages: ①The operation requires children to be over 6 years old; ②For the cases of liver cirrhosis, the liver cells have been seriously damaged, and the surgical treatment is not beneficial
Therefore, there is still a lack of a drug that is specially used for children and has mild adverse reactions for the treatment of congestive splenomegaly.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1, the weight ratio of the raw materials: 6 g of yellow grass, 8 g of bellflower, 8 g of cat's claw, 6 g of weeping grass, 6 g of pangolin, 8 g of red bean, 6 g of anemarrhena, 8 g of Citrus aurantium, 3 g of dried ginger.

Embodiment 2

[0029] Example 2, the weight ratio of the raw materials: 10 g of yellow grass, 15 g of bellflower, 15 g of cat's claw, 10 g of weeping grass, 10 g of pangolin, 15 g of red bean, 10 g of anemarrhena, 15 g of Citrus aurantium, and 6 g of dried ginger.

Embodiment 3

[0030] Example 3, the weight ratio of the raw materials: 8 g of yellow grass, 10 g of bellflower, 10 g of cat's claw, 8 g of weeping grass, 8 g of pangolin, 10 g of red bean, 8 g of anemarrhena, 10 g of Citrus aurantium, 5 g of dried ginger.

[0031] When used, the traditional Chinese medicine of the present invention is decocted twice with water, and the filtrate is combined with the filtrate and taken in the morning and evening. The above-mentioned drug dosage is a single daily dose. Children over 10 years old take the full dose, 5-10 years old take half the dose, and 1 to 5 years old take 1 / 4 dose.

[0032] The effective combination of the above-mentioned drugs and coordination with each other can effectively achieve the purpose of treating congestive splenomegaly in children with fewer side effects. The above results are fully proved by clinical data. The relevant data are as follows. The study drug used is the weight ratio of the raw material in Example 3.

[0033] 1 Objects an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating children with congestive splenomegaly, and aims to solve the problem of the treating the children with the congestive splenomegaly. The medicine is characterized by being prepared by adopting multiple plurality of traditional Chinese medicines, and the formula of the raw materials and the weight proportion are as follows: 6 to 10 parts of penthorum chinense pursh, 8 to 15 parts of rust-coloured crotalaria herb with root, 8 to 15 parts of ternate buttercup roots, 6 to 10 parts of sedum sarmentosum, 6 to 10 parts of manis pentadactyla, 8 to 15 parts of phaseolus calcaratus, 6 to 10 parts of rhizoma anemarrhenae, 8 to 15 parts of immature bitter oranges and 3 to 6 parts of rhizoma zingiberis. The clinical experiment proves that the medicine has the characteristics of good treatment effect and higher safety during the treatment of the children with the congestive splenomegaly. Therefore, the medicine is worthy of clinical applications and popularization.

Description

Technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating congestive splenomegaly in children. Background technique [0002] Chronic congestive splenomegaly (chronic congestive splenomegaly), also known as portal hypertension (portal hypertension), is a congestive chronic progressive disease of unknown cause. The clinical features are chronic progressive splenomegaly, progressive anemia, white blood cells and platelets Reduction and gastrointestinal bleeding are the main manifestations, and signs of ascites, jaundice, liver dysfunction and liver cirrhosis appear in the late stage. [0003] Chronic congestive splenomegaly is often caused by obstruction of the portal vein due to various reasons. The splenic vein belongs to the portal vein system, and 70% of the blood in the splenic vein of normal people drains into the portal vein. If the portal vein is obstructed, congestive splenomegaly may occur due to blo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61P1/16A61P43/00A61K35/36
Inventor 武英
Owner 武英
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com